-
2
-
-
84881451115
-
Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease
-
Okamura N, Furumoto S, Harada R, et al. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease. J Nucl Med 2013; 54: 1420-1427.
-
(2013)
J Nucl Med
, vol.54
, pp. 1420-1427
-
-
Okamura, N.1
Furumoto, S.2
Harada, R.3
-
3
-
-
85056068298
-
Unidirectional influx and net accumulation of PIB
-
Blomquist G, Engler H, Nordberg A, et al. Unidirectional influx and net accumulation of PIB. Open Neuroimag J 2008; 2: 114-125.
-
(2008)
Open Neuroimag J
, vol.2
, pp. 114-125
-
-
Blomquist, G.1
Engler, H.2
Nordberg, A.3
-
4
-
-
84856056762
-
The use of PIB-PET as a dual pathological and functional biomarker in AD
-
Forsberg A, Engler H, Blomquist G, et al. The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochim Biophys Acta 2012; 1822: 380-385.
-
(2012)
Biochim Biophys Acta
, vol.1822
, pp. 380-385
-
-
Forsberg, A.1
Engler, H.2
Blomquist, G.3
-
5
-
-
79851503085
-
Early 11C-PIB frames and 18F-FDG PET measures are comparable: A study validated in a cohort of AD and FTLD patients
-
Rostomian AH, Madison C, Rabinovici GD, et al. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients. J Nucl Med 2011; 52: 173-179.
-
(2011)
J Nucl Med
, vol.52
, pp. 173-179
-
-
Rostomian, A.H.1
Madison, C.2
Rabinovici, G.D.3
-
6
-
-
79952803918
-
Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B
-
Meyer PT, Hellwig S, Amtage F, et al. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B. J Nucl Med 2011; 52: 393-400.
-
(2011)
J Nucl Med
, vol.52
, pp. 393-400
-
-
Meyer, P.T.1
Hellwig, S.2
Amtage, F.3
-
7
-
-
84930985951
-
Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis
-
Fu L, Liu L, Zhang J, et al. Comparison of dual-biomarker PIB-PET and dual-tracer PET in AD diagnosis. Eur Radiol 2014; 24: 2800-2809.
-
(2014)
Eur Radiol
, vol.24
, pp. 2800-2809
-
-
Fu, L.1
Liu, L.2
Zhang, J.3
-
8
-
-
84947969582
-
11C-PiB PET in amyloid angiopathy-related symptomatic cerebral hemorrage: Potential diagnostic value?
-
11C-PiB PET in amyloid angiopathy-related symptomatic cerebral hemorrage: potential diagnostic value? PLoS One 2015; 10: e0139926.
-
(2015)
PLoS One
, vol.10
, pp. e0139926
-
-
Farid, K.1
Hong, Y.T.2
Aigbirhio, F.L.3
-
10
-
-
0030468875
-
Simplified reference tissue model for PET receptor studies
-
Lammertsma AA and Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4(3 Pt 1): 153-158.
-
(1996)
Neuroimage
, vol.4
, Issue.3
, pp. 153-158
-
-
Lammertsma, A.A.1
Hume, S.P.2
-
11
-
-
84862529821
-
Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: Preliminary studies
-
Hsiao IT, Huang CC, Hsieh CJ, et al. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies. Eur J Nucl Med Mol Imaging 2012; 39: 613-620.
-
(2012)
Eur J Nucl Med Mol Imaging
, vol.39
, pp. 613-620
-
-
Hsiao, I.T.1
Huang, C.C.2
Hsieh, C.J.3
-
12
-
-
84961244487
-
Imaging in vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm
-
Chiotis K, Saint-Aubert L, Savitcheva I, et al. Imaging in vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm. Eur J Nucl Med Mol Imaging 2016; 43: 1686-1699.
-
(2016)
Eur J Nucl Med Mol Imaging
, vol.43
, pp. 1686-1699
-
-
Chiotis, K.1
Saint-Aubert, L.2
Savitcheva, I.3
-
13
-
-
0021271971
-
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease
-
McKhann GM, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984; 34: 939-944.
-
(1984)
Neurology
, vol.34
, pp. 939-944
-
-
McKhann, G.M.1
Drachman, D.2
Folstein, M.3
-
14
-
-
4544350756
-
Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment
-
Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240-246.
-
(2004)
J Intern Med
, vol.256
, pp. 240-246
-
-
Winblad, B.1
Palmer, K.2
Kivipelto, M.3
-
15
-
-
0032988610
-
Mild cognitive impairment: Clinical characterization and outcome
-
Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303-308.
-
(1999)
Arch Neurol
, vol.56
, pp. 303-308
-
-
Petersen, R.C.1
Smith, G.E.2
Waring, S.C.3
-
16
-
-
34447322271
-
Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria
-
Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-746.
-
(2007)
Lancet Neurol
, vol.6
, pp. 734-746
-
-
Dubois, B.1
Feldman, H.H.2
Jacova, C.3
-
17
-
-
10744232413
-
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
-
Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319.
-
(2004)
Ann Neurol
, vol.55
, pp. 306-319
-
-
Klunk, W.E.1
Engler, H.2
Nordberg, A.3
-
18
-
-
84963945616
-
18F-THK5117 as a PET tracer for assessing tau pathology
-
18F-THK5117 as a PET tracer for assessing tau pathology. J Nucl Med 2016; 57: 574-581.
-
(2016)
J Nucl Med
, vol.57
, pp. 574-581
-
-
Jonasson, M.1
Wall, A.2
Chiotis, K.3
-
19
-
-
84959912123
-
Preclinical evaluation of [F]THK-5105 enantiomers: Effects of chir-ality on its effectiveness as a tau imaging radiotracer
-
Tago T, Furumoto S, Okamura N, et al. Preclinical evaluation of [F]THK-5105 enantiomers: effects of chir-ality on its effectiveness as a tau imaging radiotracer. Mol Imaging Biol 2016; 18: 258-266.
-
(2016)
Mol Imaging Biol
, vol.18
, pp. 258-266
-
-
Tago, T.1
Furumoto, S.2
Okamura, N.3
-
20
-
-
84938996337
-
[(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease
-
Harada R, Okamura N, Furumoto S, et al. [(18)F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2015; 42: 1052-1061.
-
(2015)
Eur J Nucl Med Mol Imaging
, vol.42
, pp. 1052-1061
-
-
Harada, R.1
Okamura, N.2
Furumoto, S.3
-
21
-
-
0041569918
-
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
-
Hammers A, Allom R, Koepp MJ, et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003; 19: 224-247.
-
(2003)
Hum Brain Mapp
, vol.19
, pp. 224-247
-
-
Hammers, A.1
Allom, R.2
Koepp, M.J.3
-
22
-
-
84873655842
-
A European multi-centre PET study of fibrillar amyloid in Alzheimer's disease
-
Nordberg A, Carter SF, Rinne J, et al. A European multi-centre PET study of fibrillar amyloid in Alzheimer's disease. Eur J Nucl Med Mol Imaging 2013; 40: 104-114.
-
(2013)
Eur J Nucl Med Mol Imaging
, vol.40
, pp. 104-114
-
-
Nordberg, A.1
Carter, S.F.2
Rinne, J.3
-
23
-
-
33751111992
-
Biological parametric mapping: A statistical toolbox for multimodality brain image analysis
-
Casanova R. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 2007; 34: 137-143.
-
(2007)
Neuroimage
, vol.34
, pp. 137-143
-
-
Casanova, R.1
-
24
-
-
79952709519
-
PROC: An open-source package for R and S+ to analyze and compare ROC curves
-
Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform 2011; 12: 1-8.
-
(2011)
BMC Bioinform
, vol.12
, pp. 1-8
-
-
Robin, X.1
Turck, N.2
Hainard, A.3
-
25
-
-
84926443676
-
Cocor: A comprehensive solution for the statistical comparison of correlations
-
Diedenhofen B and Musch J. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS One 2015; 10: e0121945.
-
(2015)
PLoS One
, vol.10
, pp. e0121945
-
-
Diedenhofen, B.1
Musch, J.2
-
26
-
-
0020964377
-
Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease
-
de Leon MJ, Ferris SH, George AE, et al. Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease. J Cereb Blood Flow Metab 1983; 3: 391-394.
-
(1983)
J Cereb Blood Flow Metab
, vol.3
, pp. 391-394
-
-
De Leon, M.J.1
Ferris, S.H.2
George, A.E.3
-
27
-
-
0021923110
-
Pathological and positron emission tomographic correlations in Alzheimer's disease
-
Friedland RP, Brun A and Budinger TF. Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet 1985; 1: 228.
-
(1985)
Lancet
, vol.1
, pp. 228
-
-
Friedland, R.P.1
Brun, A.2
Budinger, T.F.3
-
28
-
-
0028280849
-
The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: A population-based study
-
Claus JJ, van Harskamp F, Breteler MM, et al. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Neurology 1994; 44(3 Pt 1): 454-461.
-
(1994)
Neurology
, vol.44
, Issue.3
, pp. 454-461
-
-
Claus, J.J.1
Van Harskamp, F.2
Breteler, M.M.3
-
29
-
-
77954560273
-
Arterial spin labeling blood flow MRI: Its role in the early characterization of Alzheimer's disease
-
Alsop DC, Dai W, Grossman M, et al. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 2010; 20: 871-880.
-
(2010)
J Alzheimers Dis
, vol.20
, pp. 871-880
-
-
Alsop, D.C.1
Dai, W.2
Grossman, M.3
-
30
-
-
0345161819
-
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease
-
Backman L, Andersson JL, Nyberg L, et al. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology 1999; 52: 1861-1870.
-
(1999)
Neurology
, vol.52
, pp. 1861-1870
-
-
Backman, L.1
Andersson, J.L.2
Nyberg, L.3
-
31
-
-
0024561561
-
Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain
-
Yamaguchi H, Hirai S, Morimatsu M, et al. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain. Acta Neuropathol 1989; 77: 314-319.
-
(1989)
Acta Neuropathol
, vol.77
, pp. 314-319
-
-
Yamaguchi, H.1
Hirai, S.2
Morimatsu, M.3
-
32
-
-
0028347949
-
Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: A study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
-
Mirra SS, Gearing M, McKeel DW Jr, et al. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J Neuropathol Exp Neurol 1994; 53: 303-315.
-
(1994)
J Neuropathol Exp Neurol
, vol.53
, pp. 303-315
-
-
Mirra, S.S.1
Gearing, M.2
McKeel, D.W.3
-
33
-
-
0029094457
-
Preserved pon-tine glucose metabolism in Alzheimer disease: A reference region for functional brain image (PET) analysis
-
Minoshima S, Frey KA, Foster NL, et al. Preserved pon-tine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 1995; 19: 541-547.
-
(1995)
J Comput Assist Tomogr
, vol.19
, pp. 541-547
-
-
Minoshima, S.1
Frey, K.A.2
Foster, N.L.3
-
34
-
-
0036743220
-
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
-
Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17: 302-316.
-
(2002)
Neuroimage
, vol.17
, pp. 302-316
-
-
Herholz, K.1
Salmon, E.2
Perani, D.3
-
35
-
-
0028341567
-
Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia
-
Talbot PR, Lloyd JJ, Snowden JS, et al. Choice of reference region in the quantification of single-photon emission tomography in primary degenerative dementia. Eur J Nucl Med 1994; 21: 503-508.
-
(1994)
Eur J Nucl Med
, vol.21
, pp. 503-508
-
-
Talbot, P.R.1
Lloyd, J.J.2
Snowden, J.S.3
-
36
-
-
0033606144
-
Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type
-
Pickut BA, Dierckx RA, Dobbeleir A, et al. Validation of the cerebellum as a reference region for SPECT quantification in patients suffering from dementia of the Alzheimer type. Psychiatry Res 1999; 90: 103-112.
-
(1999)
Psychiatry Res
, vol.90
, pp. 103-112
-
-
Pickut, B.A.1
Dierckx, R.A.2
Dobbeleir, A.3
-
37
-
-
84941426553
-
Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: Two sides of the same coin?
-
Verfaillie SC, Adriaanse SM, Binnewijzend MA, et al. Cerebral perfusion and glucose metabolism in Alzheimer's disease and frontotemporal dementia: two sides of the same coin? Eur Radiol 2015; 25: 3050-3059.
-
(2015)
Eur Radiol
, vol.25
, pp. 3050-3059
-
-
Verfaillie, S.C.1
Adriaanse, S.M.2
Ma, B.3
-
38
-
-
84875350349
-
Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner
-
Huisman MC, van Golen LW, Hoetjes NJ, et al. Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner. EJNMMI Res 2012; 2: 1-9.
-
(2012)
EJNMMI Res
, vol.2
, pp. 1-9
-
-
Huisman, M.C.1
Van Golen, L.W.2
Hoetjes, N.J.3
-
41
-
-
85017364549
-
(1)(8)F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
-
Smailagic N, Vacante M, Hyde C, et al. (1)(8)F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2015; 1: CD010632.
-
(2015)
Cochrane Database Syst Rev
, vol.1
, pp. CD010632
-
-
Smailagic, N.1
Vacante, M.2
Hyde, C.3
|